Raras
Buscar doenças, sintomas, genes...
Surdez genética não sindrômica
ORPHA:87884CID-10 · H90.5CID-11 · AB50DOENÇA RARA

Doença caracterizada por perda auditiva que não faz parte de uma síndrome maior.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

Doença caracterizada por perda auditiva que não faz parte de uma síndrome maior.

Escala de raridade

CLASSIFICAÇÃO ORPHANET · BRASIL 2024
Unknown
Ultra-rara
<1/50k
Muito rara
1/20k
Rara
1/10k
Pouco freq.
1/5k
Incomum
1/2k
Prevalência
0.0
Worldwide
Início
Infancy
+ neonatal
🏥
SUS: Sem cobertura SUSScore: 0%
CID-10: H90.5
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

👂
Ouvidos
42 sintomas
👁️
Olhos
9 sintomas
🧠
Neurológico
7 sintomas
🩸
Sangue
3 sintomas
💪
Músculos
2 sintomas
📏
Crescimento
1 sintomas

+ 26 sintomas em outras categorias

Características mais comuns

55%prev.
Deficiência auditiva neurossensorial pós-lingual
Frequente (79-30%)
55%prev.
Deficiência auditiva neurossensorial pré-lingual
Frequente (79-30%)
55%prev.
Atraso no desenvolvimento da fala e da linguagem
Frequente (79-30%)
55%prev.
Deficiência auditiva neurossensorial progressiva
Frequente (79-30%)
55%prev.
Discriminação de fala anormal
Frequente (79-30%)
55%prev.
Deficiência auditiva neurossensorial profunda
Frequente (79-30%)
94sintomas
Frequente (6)
Ocasional (6)
Muito raro (1)
Sem dados (81)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 94 características clínicas mais associadas, ordenadas por frequência.

Deficiência auditiva neurossensorial pós-lingualPostlingual sensorineural hearing impairment
Frequente (79-30%)55%
Deficiência auditiva neurossensorial pré-lingualPrelingual sensorineural hearing impairment
Frequente (79-30%)55%
Atraso no desenvolvimento da fala e da linguagemDelayed speech and language development
Frequente (79-30%)55%
Deficiência auditiva neurossensorial progressivaProgressive sensorineural hearing impairment
Frequente (79-30%)55%
Discriminação de fala anormalAbnormal speech discrimination
Frequente (79-30%)55%

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Últimos 10 anos87publicações
Pico202316 papers
Linha do tempo
2026Hoje · 2026🧪 2010Primeiro ensaio clínico📈 2023Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

75 genes identificados com associação a esta condição. Padrão de herança: Autosomal dominant, Autosomal recessive, X-linked recessive.

AIFM1Apoptosis-inducing factor 1, mitochondrialDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Functions both as NADH oxidoreductase and as regulator of apoptosis (PubMed:17094969, PubMed:20362274, PubMed:23217327, PubMed:33168626). In response to apoptotic stimuli, it is released from the mitochondrion intermembrane space into the cytosol and to the nucleus, where it functions as a proapoptotic factor in a caspase-independent pathway (PubMed:20362274). Release into the cytoplasm is mediated upon binding to poly-ADP-ribose chains (By similarity). The soluble form (AIFsol) found in the nuc

LOCALIZAÇÃO

Mitochondrion intermembrane spaceMitochondrion inner membraneCytoplasmNucleusCytoplasm, perinuclear regionMitochondrionCytoplasm, cytosol

MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 6

A mitochondrial disease resulting in a neurodegenerative disorder characterized by psychomotor delay, hypotonia, areflexia, muscle weakness and wasting. Some patients manifest prenatal ventriculomegaly and severe postnatal encephalomyopathy.

OUTRAS DOENÇAS (4)
X-linked hereditary sensory and autonomic neuropathy with hearing lossCharcot-Marie-Tooth disease X-linked recessive 4spondyloepimetaphyseal dysplasia, Bieganski typesevere X-linked mitochondrial encephalomyopathy
HGNC:8768UniProt:O95831
ROR1Inactive tyrosine-protein kinase transmembrane receptor ROR1Candidate gene tested inAltamente restrito
FUNÇÃO

Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo (PubMed:25029443). Receptor for ligand WNT5A which activate downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443, PubMed:27162350). In inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells (PubMed:27162350). Via IGFBP5 ligand, forms a complex with ERBB2 to enhance CREB oncogenic signaling (PubMed:36949068)

LOCALIZAÇÃO

MembraneCell projection, axon

VIAS BIOLÓGICAS (1)
WNT5A-dependent internalization of FZD2, FZD5 and ROR2
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 108

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
18.3 TPM
Fibroblastos
14.1 TPM
Aorta
11.3 TPM
Artéria coronária
9.2 TPM
Cervix Endocervix
7.8 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 108hearing loss, autosomal recessive
HGNC:10256UniProt:Q01973
GIPC3PDZ domain-containing protein GIPC3Candidate gene tested inTolerante
FUNÇÃO

Required for postnatal maturation of the hair bundle and long-term survival of hair cells and spiral ganglion

LOCALIZAÇÃO

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 15

A form of non-syndromic sensorineural hearing loss with prelingual onset. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Muscular
14.9 TPM
Pulmão
8.0 TPM
Esôfago - Junção
7.9 TPM
Tecido adiposo
7.6 TPM
Baço
7.2 TPM
INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 15hearing loss, autosomal recessive
HGNC:18183UniProt:Q8TF64
TRRAPTransformation/transcription domain-associated proteinCandidate gene tested inAltamente restrito
FUNÇÃO

Adapter protein, which is found in various multiprotein chromatin complexes with histone acetyltransferase activity (HAT), which gives a specific tag for epigenetic transcription activation. Component of the NuA4 histone acetyltransferase complex which is responsible for acetylation of nucleosomal histones H4 and H2A. Plays a central role in MYC transcription activation, and also participates in cell transformation by MYC. Required for p53/TP53-, E2F1- and E2F4-mediated transcription activation.

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (3)
Formation of the beta-catenin:TCF transactivating complexHATs acetylate histonesUb-specific processing proteases
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
28.7 TPM
Pituitária
27.2 TPM
Testículo
25.9 TPM
Fibroblastos
25.3 TPM
Cerebelo
24.8 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 75developmental delay with or without dysmorphic facies and autismautosomal dominant nonsyndromic hearing loss
HGNC:12347UniProt:Q9Y4A5
TMC1Transmembrane channel-like protein 1Candidate gene tested inTolerante
FUNÇÃO

Pore-forming subunit of the mechanotransducer (MET) non-selective cation channel complex located at the tips of stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system (By similarity). The MET complex is composed of two dimeric pore-forming ion-conducting transmembrane TMC (TMC1 or TMC2) subunits, and aided by several auxiliary proteins including LHFPL5, TMIE, CIB2/3 and TOMT, and the tip-link PCDH15 (By similarity). MET channel is activated by tension in

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 36

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA36 is a bilateral hearing loss, and begins at 5-10 years of age. It progresses to profound deafness within 10-15 years.

EXPRESSÃO TECIDUAL(Baixa expressão)
Testículo
1.4 TPM
Esôfago - Mucosa
0.7 TPM
Brain Spinal cord cervical c-1
0.6 TPM
Próstata
0.4 TPM
Vagina
0.3 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 7autosomal dominant nonsyndromic hearing loss 36autosomal dominant nonsyndromic hearing losshearing loss, autosomal recessive
HGNC:16513UniProt:Q8TDI8
DMXL2DmX-like protein 2Candidate gene tested inAltamente restrito
FUNÇÃO

May serve as a scaffold protein for MADD and RAB3GA on synaptic vesicles (PubMed:11809763). Plays a role in the brain as a key controller of neuronal and endocrine homeostatic processes (By similarity)

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneCytoplasmic vesicle, secretory vesicle, neuronal dense core vesicle

MECANISMO DE DOENÇA

Polyendocrine-polyneuropathy syndrome

A progressive endocrine and neurodevelopmental disorder manifesting early in childhood with growth retardation and recurrent episodes of profound asymptomatic hypoglycemia. PEPNS is characterized by central hypothyroidism, hypogonadotropic hypogonadism, incomplete puberty, progressive non-autoimmune insulin-dependent diabetes mellitus, peripheral demyelinating sensorimotor polyneuropathy, and cerebellar and pyramidal signs.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
22.0 TPM
Cerebelo
20.8 TPM
Pituitária
16.6 TPM
Pulmão
14.8 TPM
Testículo
13.9 TPM
OUTRAS DOENÇAS (5)
developmental and epileptic encephalopathy, 81polyendocrine-polyneuropathy syndromehearing loss, autosomal dominant 71early-infantile DEE
HGNC:2938UniProt:Q8TDJ6
PNPT1Polyribonucleotide nucleotidyltransferase 1, mitochondrialCandidate gene tested inRestrito
FUNÇÃO

RNA-binding protein implicated in numerous RNA metabolic processes (PubMed:29967381, PubMed:39019044). Catalyzes the phosphorolysis of single-stranded polyribonucleotides processively in the 3'-to-5' direction (PubMed:29967381, PubMed:39019044). Mitochondrial intermembrane factor with RNA-processing exoribonulease activity (PubMed:29967381, PubMed:39019044). Component of the mitochondrial degradosome (mtEXO) complex, that degrades 3' overhang double-stranded RNA with a 3'-to-5' directionality in

LOCALIZAÇÃO

CytoplasmMitochondrion matrixMitochondrion intermembrane space

VIAS BIOLÓGICAS (1)
Mitochondrial RNA degradation
MECANISMO DE DOENÇA

Combined oxidative phosphorylation deficiency 13

A mitochondrial disorder characterized by early onset severe encephalomyopathy, dystonia, choreoathetosis, bucofacial dyskinesias and combined mitochondrial respiratory chain deficiency. Nerve conductions velocities are decreased. Levels of plasma and cerebrospinal fluid lactate are increased.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
39.7 TPM
Fibroblastos
26.0 TPM
Cérebro - Hemisfério cerebelar
21.3 TPM
Brain Spinal cord cervical c-1
20.7 TPM
Testículo
20.4 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 25combined oxidative phosphorylation defect type 13autosomal recessive nonsyndromic hearing loss 70hearing loss, autosomal recessive
HGNC:23166UniProt:Q8TCS8
DCDC2Doublecortin domain-containing protein 2Candidate gene tested inTolerante
FUNÇÃO

Protein that plays a role in the inhibition of canonical Wnt signaling pathway (PubMed:25557784). May be involved in neuronal migration during development of the cerebral neocortex (By similarity). Involved in the control of ciliogenesis and ciliary length (PubMed:25601850, PubMed:27319779)

LOCALIZAÇÃO

Cell projection, ciliumCytoplasm, cytoskeleton, cilium axonemeCell projection, kinociliumCytoplasm, cytoskeleton

MECANISMO DE DOENÇA

Dyslexia 2

A relatively common, complex cognitive disorder characterized by an impairment of reading performance despite adequate motivational, educational and intellectual opportunities. It is a multifactorial trait, with evidence for familial clustering and heritability.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
32.6 TPM
Rim - Córtex
19.0 TPM
Pâncreas
8.7 TPM
Testículo
7.0 TPM
Tireoide
6.9 TPM
OUTRAS DOENÇAS (5)
isolated neonatal sclerosing cholangitisautosomal recessive nonsyndromic hearing loss 66nephronophthisis 19Senior-Boichis syndrome
HGNC:18141UniProt:Q9UHG0
TECTAAlpha-tectorinCandidate gene tested inTolerante
FUNÇÃO

One of the major non-collagenous components of the tectorial membrane (By similarity). The tectorial membrane is an extracellular matrix of the inner ear that covers the neuroepithelium of the cochlea and contacts the stereocilia bundles of specialized sensory hair cells. Sound induces movement of these hair cells relative to the tectorial membrane, deflects the stereocilia and leads to fluctuations in hair-cell membrane potential, transducing sound into electrical signals

LOCALIZAÇÃO

Cell membraneSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Post-translational modification: synthesis of GPI-anchored proteins
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 12

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Baixa expressão)
Cerebelo
3.3 TPM
Pituitária
3.0 TPM
Cérebro - Hemisfério cerebelar
2.9 TPM
Testículo
2.7 TPM
Tireoide
2.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 12autosomal recessive nonsyndromic hearing loss 21nonsyndromic genetic hearing losshearing loss, autosomal recessive
HGNC:11720UniProt:O75443
BDP1Transcription factor TFIIIB component B'' homologCandidate gene tested inTolerante
FUNÇÃO

General activator of RNA polymerase III transcription. Requires for transcription from all three types of polymerase III promoters. Requires for transcription of genes with internal promoter elements and with promoter elements upstream of the initiation site

LOCALIZAÇÃO

Nucleus

VIAS BIOLÓGICAS (4)
RNA Polymerase III Abortive And Retractive InitiationRNA Polymerase III Transcription Initiation From Type 1 PromoterRNA Polymerase III Transcription Initiation From Type 2 PromoterRNA Polymerase III Transcription Initiation From Type 3 Promoter
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 112

A form of non-syndromic, sensorineural deafness characterized by postlingual progressive hearing impairment. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 112hearing loss, autosomal recessive
HGNC:13652UniProt:A6H8Y1
CCDC50Coiled-coil domain-containing protein 50Candidate gene tested inTolerante
FUNÇÃO

Involved in EGFR signaling

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 44

A form of non-syndromic deafness characterized by initially moderate hearing loss that affects mainly low to mid frequencies. Later, it progresses to involve all the frequencies and leads to a profound hearing loss by the 6th decade.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 44autosomal dominant nonsyndromic hearing loss
HGNC:18111UniProt:Q8IVM0
MAP1BMicrotubule-associated protein 1BCandidate gene tested inAltamente restrito
FUNÇÃO

Facilitates tyrosination of alpha-tubulin in neuronal microtubules (By similarity). Phosphorylated MAP1B is required for proper microtubule dynamics and plays a role in the cytoskeletal changes that accompany neuronal differentiation and neurite extension (PubMed:33268592). Possibly MAP1B binds to at least two tubulin subunits in the polymer, and this bridging of subunits might be involved in nucleating microtubule polymerization and in stabilizing microtubules. Acts as a positive cofactor in DA

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasmSynapseCell projection, dendritic spine

VIAS BIOLÓGICAS (1)
RSV-host interactions
MECANISMO DE DOENÇA

Periventricular nodular heterotopia 9

A form of periventricular nodular heterotopia, a disorder resulting from a defect in the pattern of neuronal migration in which ectopic collections of neurons lie along the lateral ventricles of the brain or just beneath, contiguously or in isolated patches. PVNH9 is an autosomal dominant disorder with incomplete penetrance, characterized by impaired intellectual development, cognitive defects, learning disabilities, and behavior abnormalities. Some patients develop seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
262.6 TPM
Cerebelo
227.2 TPM
Brain Frontal Cortex BA9
180.1 TPM
Aorta
169.2 TPM
Brain Spinal cord cervical c-1
158.9 TPM
OUTRAS DOENÇAS (4)
periventricular nodular heterotopia 9hearing loss, autosomal dominant 83periventricular nodular heterotopiaautosomal dominant nonsyndromic hearing loss
HGNC:6836UniProt:P46821
CENPPCentromere protein PCandidate gene tested inTolerante
FUNÇÃO

Component of the CENPA-CAD (nucleosome distal) complex, a complex recruited to centromeres which is involved in assembly of kinetochore proteins, mitotic progression and chromosome segregation. May be involved in incorporation of newly synthesized CENPA into centromeres via its interaction with the CENPA-NAC complex

LOCALIZAÇÃO

NucleusChromosome, centromere

VIAS BIOLÓGICAS (6)
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signalRHO GTPases Activate ForminsMitotic PrometaphaseEML4 and NUDC in mitotic spindle formationResolution of Sister Chromatid Cohesion
OUTRAS DOENÇAS (1)
autosomal dominant nonsyndromic hearing loss
HGNC:32933UniProt:Q6IPU0
CD164Sialomucin core protein 24Candidate gene tested inModerado
FUNÇÃO

Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast mig

LOCALIZAÇÃO

Lysosome membraneEndosome membraneCell membraneSecreted

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 66

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 66autosomal dominant nonsyndromic hearing loss
HGNC:1632UniProt:Q04900
OTOGLOtogelin-like proteinCandidate gene tested inTolerante
LOCALIZAÇÃO

Secreted

VIAS BIOLÓGICAS (1)
Sensory processing of sound by outer hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 84B

A form of non-syndromic deafness characterized by congenital, non-progressive, sensorineural, symmetric hearing loss. Vestibular hypofunction is rarely observed.

EXPRESSÃO TECIDUAL(Baixa expressão)
Coração - Átrio
4.2 TPM
Pituitária
1.6 TPM
Córtex cerebral
1.3 TPM
Cólon sigmoide
1.3 TPM
Esôfago - Muscular
1.2 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 84Bhearing loss, autosomal recessive
HGNC:26901UniProt:Q3ZCN5
SYNE4Nesprin-4Candidate gene tested inTolerante
FUNÇÃO

As a component of the LINC (LInker of Nucleoskeleton and Cytoskeleton) complex, involved in the connection between the nuclear lamina and the cytoskeleton. The nucleocytoplasmic interactions established by the LINC complex play an important role in the transmission of mechanical forces across the nuclear envelope and in nuclear movement and positioning (By similarity). Behaves as a kinesin cargo, providing a functional binding site for kinesin-1 at the nuclear envelope. Hence may contribute to t

LOCALIZAÇÃO

Nucleus outer membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 76

A form of non-syndromic sensorineural deafness, a disorder resulting from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB76 affected individuals have onset of progressive high frequency hearing impairment between birth and 6 years of age. The hearing loss is severe at high frequencies by adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Cérebro - Hemisfério cerebelar
39.5 TPM
Cerebelo
37.3 TPM
Pituitária
36.1 TPM
Tireoide
30.0 TPM
Próstata
25.7 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 76hearing loss, autosomal recessive
HGNC:26703UniProt:Q8N205
WHRNWhirlinCandidate gene tested inTolerante
FUNÇÃO

Involved in hearing and vision as member of the USH2 complex. Necessary for elongation and maintenance of inner and outer hair cell stereocilia in the organ of Corti in the inner ear. Involved in the maintenance of the hair bundle ankle region, which connects stereocilia in cochlear hair cells of the inner ear. In retina photoreceptors, required for the maintenance of periciliary membrane complex that seems to play a role in regulating intracellular protein transport

LOCALIZAÇÃO

CytoplasmCell projection, stereociliumCell projection, growth conePhotoreceptor inner segmentSynapse

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 31

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Glândula adrenal
101.0 TPM
Testículo
78.7 TPM
Pituitária
61.5 TPM
Útero
52.7 TPM
Ovário
35.9 TPM
OUTRAS DOENÇAS (4)
Usher syndrome type 2Dautosomal recessive nonsyndromic hearing loss 31Usher syndrome type 2hearing loss, autosomal recessive
HGNC:16361UniProt:Q9P202
PDE1CDual specificity calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1CCandidate gene tested inTolerante
FUNÇÃO

Calmodulin-dependent cyclic nucleotide phosphodiesterase with a dual specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes (PubMed:29860631, PubMed:8557689). Has a high affinity for both cAMP and cGMP (PubMed:8557689). Modulates the amplitude and duration of the cAMP signal in sensory cilia in response to odorant stimulation, hence contributing to the generation of action potentials. Regulates smooth muscle cell proliferation. Reg

LOCALIZAÇÃO

Lysosome

VIAS BIOLÓGICAS (1)
Cam-PDE 1 activation
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 74

A form of non-syndromic deafness characterized by progressive, postlingual hearing loss with onset in the third decade of life.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Coração - Ventrículo esquerdo
14.4 TPM
Brain Spinal cord cervical c-1
13.3 TPM
Fallopian Tube
12.2 TPM
Coração - Átrio
9.9 TPM
Bladder
8.4 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal dominant 74autosomal dominant nonsyndromic hearing loss
HGNC:8776UniProt:Q14123
MYO1AUnconventional myosin-IaCandidate gene tested inTolerante
FUNÇÃO

Involved in directing the movement of organelles along actin filaments

LOCALIZAÇÃO

Cell projection, microvillus

MECANISMO DE DOENÇA

Diarrhea 15, congenital

An autosomal recessive disorder characterized by severe diarrhea manifesting in infancy and resolving by the second year of life.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
103.4 TPM
Cólon transverso
51.6 TPM
Brain Spinal cord cervical c-1
9.6 TPM
Estômago
4.3 TPM
Testículo
2.7 TPM
OUTRAS DOENÇAS (2)
diarrhea 15, congenitalautosomal dominant nonsyndromic hearing loss
HGNC:7595UniProt:Q9UBC5
PRPS1Ribose-phosphate pyrophosphokinase 1Candidate gene tested inAltamente restrito
FUNÇÃO

Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) that is essential for nucleotide synthesis

LOCALIZAÇÃO

VIAS BIOLÓGICAS (1)
5-Phosphoribose 1-diphosphate biosynthesis
EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
78.0 TPM
Cérebro - Hemisfério cerebelar
64.3 TPM
Fibroblastos
58.6 TPM
Cerebelo
51.2 TPM
Tireoide
51.1 TPM
OUTRAS DOENÇAS (8)
phosphoribosylpyrophosphate synthetase superactivityCharcot-Marie-Tooth disease X-linked recessive 5Arts syndromehearing loss, X-linked 1
HGNC:9462UniProt:P60891
MARVELD2MARVEL domain-containing protein 2Candidate gene tested inTolerante
FUNÇÃO

Plays a role in the formation of tricellular tight junctions and of epithelial barriers (By similarity). Required for normal hearing via its role in the separation of the endolymphatic and perilymphatic spaces of the organ of Corti in the inner ear, and for normal survival of hair cells in the organ of Corti (PubMed:17186462)

LOCALIZAÇÃO

Cell membraneCell junction, tight junction

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 49

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
18.1 TPM
Rim - Medula
9.6 TPM
Esôfago - Mucosa
8.5 TPM
Estômago
7.8 TPM
Pulmão
7.6 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 49hearing loss, autosomal recessive
HGNC:26401UniProt:Q8N4S9
GPSM2G-protein-signaling modulator 2Candidate gene tested inTolerante
FUNÇÃO

Plays an important role in mitotic spindle pole organization via its interaction with NUMA1 (PubMed:11781568, PubMed:15632202, PubMed:21816348). Required for cortical dynein-dynactin complex recruitment during metaphase (PubMed:22327364). Plays a role in metaphase spindle orientation (PubMed:22327364). Also plays an important role in asymmetric cell divisions (PubMed:21816348). Has guanine nucleotide dissociation inhibitor (GDI) activity towards G(i) alpha proteins, such as GNAI1 and GNAI3, and

LOCALIZAÇÃO

CytoplasmCytoplasm, cell cortexCytoplasm, cytoskeleton, spindle poleLateral cell membrane

VIAS BIOLÓGICAS (1)
G alpha (i) signalling events
MECANISMO DE DOENÇA

Chudley-McCullough syndrome

An autosomal recessive neurologic disorder characterized by early-onset sensorineural deafness and specific brain anomalies on MRI, including hypoplasia of the corpus callosum, enlarged cysterna magna with mild focal cerebellar dysplasia, and nodular heterotopia. Some patients have hydrocephalus. Psychomotor development is normal.

EXPRESSÃO TECIDUAL(Ubíquo)
Brain Spinal cord cervical c-1
20.9 TPM
Skin Sun Exposed Lower leg
19.4 TPM
Skin Not Sun Exposed Suprapubic
19.1 TPM
Esôfago - Mucosa
18.7 TPM
Vagina
14.6 TPM
OUTRAS DOENÇAS (2)
Chudley-McCullough syndromehearing loss, autosomal recessive
HGNC:29501UniProt:P81274
AFG2BATPase family gene 2 protein homolog BCandidate gene tested inTolerante
FUNÇÃO

ATP-dependent chaperone part of the 55LCC heterohexameric ATPase complex which is chromatin-associated and promotes replisome proteostasis to maintain replication fork progression and genome stability. Required for replication fork progression, sister chromatid cohesion, and chromosome stability. The ATPase activity is specifically enhanced by replication fork DNA and is coupled to cysteine protease-dependent cleavage of replisome substrates in response to replication fork damage. Uses ATPase ac

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeleton, spindleNucleus

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 119

A form of non-syndromic deafness characterized by mild to profound sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (3)
neurodevelopmental disorder with hearing loss and spasticityhearing loss, autosomal recessive 119hearing loss, autosomal recessive
HGNC:28762UniProt:Q9BVQ7
PJVKPejvakinCandidate gene tested inTolerante
FUNÇÃO

Peroxisome-associated protein required to protect auditory hair cells against noise-induced damage. Acts by regulating noise-induced peroxisome proliferation in auditory hair cells and neurons, and promoting autophagic degradation of damaged peroxisomes (pexophagy). Noise overexposure increases reactive oxygen species (ROS) levels, causing oxidative damage to auditory hair cells and resulting in hearing loss. PJVK acts as a ROS sensor that recruits the autophagy machinery to trigger pexophagy of

LOCALIZAÇÃO

Peroxisome membraneCell projection, cilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 59

A form of sensorineural hearing impairment with absent or severely abnormal auditory brainstem response but normal otoacoustic emissions (auditory neuropathy or auditory dys-synchrony). Auditory neuropathies result from a lesion in the area including the inner hair cells, connections between the inner hair cells and the cochlear branch of the auditory nerve, the auditory nerve itself and auditory pathways of the brainstem.

OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 59hearing loss, autosomal recessive
HGNC:29502UniProt:Q0ZLH3
GJB3Gap junction beta-3 proteinCandidate gene tested inTolerante
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 1

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
184.0 TPM
Skin Not Sun Exposed Suprapubic
182.9 TPM
Esôfago - Mucosa
87.3 TPM
Vagina
41.6 TPM
Próstata
4.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (7)
autosomal dominant nonsyndromic hearing loss 2Bautosomal recessive nonsyndromic hearing loss 1Aerythrokeratodermia variabilis et progressiva 1hearing loss, autosomal recessive
HGNC:4285UniProt:O75712
WFS1WolframinCandidate gene tested inTolerante
FUNÇÃO

Participates in the regulation of cellular Ca(2+) homeostasis, at least partly, by modulating the filling state of the endoplasmic reticulum Ca(2+) store (PubMed:16989814). Negatively regulates the ER stress response and positively regulates the stability of V-ATPase subunits ATP6V1A and ATP1B1 by preventing their degradation through an unknown proteasome-independent mechanism (PubMed:23035048)

LOCALIZAÇÃO

Endoplasmic reticulum membraneCytoplasmic vesicle, secretory vesicle

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Wolfram syndrome 1

A rare disorder characterized by juvenile-onset insulin-dependent diabetes mellitus with optic atrophy. Other manifestations include diabetes insipidus, sensorineural deafness, dementia, psychiatric illnesses.

EXPRESSÃO TECIDUAL(Ubíquo)
Ovário
209.9 TPM
Útero
191.1 TPM
Aorta
160.6 TPM
Fallopian Tube
157.4 TPM
Artéria tibial
151.6 TPM
OUTRAS DOENÇAS (8)
Wolfram syndrome 1Wolfram-like syndromeautosomal dominant nonsyndromic hearing loss 6cataract 41
HGNC:12762UniProt:O76024
CRYMKetimine reductase mu-crystallinCandidate gene tested inTolerante
FUNÇÃO

Catalyzes the NAD(P)H-dependent reduction of imine double bonds of a number of cyclic ketimine substrates, including sulfur-containing cyclic ketimines (PubMed:21332720, PubMed:25931162). Under physiological conditions, it efficiently catalyzes delta(1)-piperideine-2-carboxylate (P2C) and delta(1)-pyrroline-2-carboxylate (Pyr2C) reduction, suggesting a central role in lysine and glutamate metabolism (PubMed:25931162). Additional substrates are delta(2)-thiazoline-2-carboxylate (T2C), 3,4-dehydro

LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Lysine catabolism
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 40

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Brain Nucleus accumbens basal ganglia
153.7 TPM
Cérebro - Hemisfério cerebelar
150.5 TPM
Cerebelo
121.9 TPM
Brain Frontal Cortex BA9
90.3 TPM
Córtex cerebral
70.0 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 40autosomal dominant nonsyndromic hearing loss
HGNC:2418UniProt:Q14894
DIAPH3Protein diaphanous homolog 3Candidate gene tested inTolerante
FUNÇÃO

Actin nucleation and elongation factor required for the assembly of F-actin structures, such as actin cables and stress fibers. Required for cytokinesis, stress fiber formation and transcriptional activation of the serum response factor. Binds to GTP-bound form of Rho and to profilin: acts in a Rho-dependent manner to recruit profilin to the membrane, where it promotes actin polymerization. DFR proteins couple Rho and Src tyrosine kinase during signaling and the regulation of actin dynamics. Als

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (10)
RHO GTPases Activate ForminsRAC3 GTPase cycleRHOJ GTPase cycleRHOG GTPase cycleRHOF GTPase cycle
MECANISMO DE DOENÇA

Auditory neuropathy, autosomal dominant 1

A form of sensorineural hearing loss with absent or severely abnormal auditory brainstem response, in the presence of normal cochlear outer hair cell function and normal otoacoustic emissions. Auditory neuropathies result from a lesion in the area including the inner hair cells, connections between the inner hair cells and the cochlear branch of the auditory nerve, the auditory nerve itself and auditory pathways of the brainstem. Affected individuals typically respond to sound but have difficulties in speech discrimination.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
20.9 TPM
Linfócitos
15.0 TPM
Fibroblastos
11.9 TPM
Esôfago - Mucosa
2.7 TPM
Aorta
2.5 TPM
OUTRAS DOENÇAS (2)
autosomal dominant auditory neuropathy 1autosomal dominant nonsyndromic hearing loss
HGNC:15480UniProt:Q9NSV4
RESTRE1-silencing transcription factorDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcriptional repressor which binds neuron-restrictive silencer element (NRSE) and represses neuronal gene transcription in non-neuronal cells (PubMed:11741002, PubMed:11779185, PubMed:12399542, PubMed:26551668, PubMed:7697725, PubMed:7871435, PubMed:8568247). Restricts the expression of neuronal genes by associating with two distinct corepressors, SIN3A and RCOR1, which in turn recruit histone deacetylase to the promoters of REST-regulated genes (PubMed:10449787, PubMed:10734093). Mediates re

LOCALIZAÇÃO

NucleusCytoplasm

VIAS BIOLÓGICAS (5)
Regulation of PTEN gene transcriptionPotential therapeutics for SARSHDACs deacetylate histonesNGF-stimulated transcriptionRegulation of NPAS4 gene transcription
MECANISMO DE DOENÇA

Wilms tumor 6

A pediatric malignancy of kidney, and the most common childhood abdominal malignancy. It is caused by the uncontrolled multiplication of renal stem, stromal, and epithelial cells.

EXPRESSÃO TECIDUAL(Ubíquo)
Fibroblastos
18.7 TPM
Testículo
16.2 TPM
Linfócitos
15.0 TPM
Nervo tibial
14.5 TPM
Ovário
13.4 TPM
OUTRAS DOENÇAS (5)
fibromatosis, gingival, 5autosomal dominant nonsyndromic hearing loss 27hereditary gingival fibromatosiskidney Wilms tumor
HGNC:9966UniProt:Q13127
POU4F3POU domain, class 4, transcription factor 3Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Acts as a transcriptional activator (PubMed:18228599). Acts by binding to sequences related to the consensus octamer motif 5'-ATGCAAAT-3' in the regulatory regions of its target genes (PubMed:18228599). Involved in the auditory system development, required for terminal differentiation of hair cells in the inner ear (By similarity)

LOCALIZAÇÃO

NucleusCytoplasm

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 15

A form of non-syndromic hearing loss with variable phenotype in terms of age at onset, levels of progression, and shape of audiograms.

EXPRESSÃO TECIDUAL(Não detectado)
Nervo tibial
0.2 TPM
Aorta
0.2 TPM
Artéria tibial
0.2 TPM
Skin Sun Exposed Lower leg
0.2 TPM
Brain Spinal cord cervical c-1
0.1 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 15autosomal dominant nonsyndromic hearing loss
HGNC:9220UniProt:Q15319
COL11A2Collagen alpha-2(XI) chainDisease-causing germline mutation(s) inRestrito
FUNÇÃO

May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Collagen biosynthesis and modifying enzymesCollagen chain trimerization
MECANISMO DE DOENÇA

Otospondylomegaepiphyseal dysplasia, autosomal dominant

An autosomal dominant form of otospondylomegaepiphyseal dysplasia, a disorder characterized by sensorineural deafness, enlarged epiphyses, mild platyspondyly, and disproportionate shortness of the limbs. Total body length is normal. Typical facial features are mid-face hypoplasia, short upturned nose and depressed nasal bridge. Most patients have Pierre Robin sequence including an opening in the roof of the mouth (cleft palate) and a small lower jaw (micrognathia). Ocular symptoms are absent. Some patients have early-onset osteoarthritis.

OUTRAS DOENÇAS (9)
otospondylomegaepiphyseal dysplasia, autosomal dominantotospondylomegaepiphyseal dysplasia, autosomal recessiveautosomal dominant nonsyndromic hearing loss 13autosomal recessive nonsyndromic hearing loss 53
HGNC:2187UniProt:P13942
EPS8L2Epidermal growth factor receptor kinase substrate 8-like protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Stimulates guanine exchange activity of SOS1. May play a role in membrane ruffling and remodeling of the actin cytoskeleton. In the cochlea, is required for stereocilia maintenance in adult hair cells (By similarity)

LOCALIZAÇÃO

CytoplasmCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 106

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Esôfago - Mucosa
262.4 TPM
Tireoide
184.2 TPM
Vagina
168.2 TPM
Rim - Medula
141.4 TPM
Glândula salivar
131.6 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 106hearing loss, autosomal recessive
HGNC:21296UniProt:Q9H6S3
TMPRSS3Transmembrane protease serine 3Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Probable serine protease that plays a role in hearing. Acts as a permissive factor for cochlear hair cell survival and activation at the onset of hearing and is required for saccular hair cell survival (By similarity). Activates ENaC (in vitro)

LOCALIZAÇÃO

Endoplasmic reticulum membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 8

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Glândula salivar
7.6 TPM
Linfócitos
7.1 TPM
Tireoide
5.4 TPM
Rim - Medula
4.2 TPM
Pituitária
4.1 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 8hearing loss, autosomal recessive
HGNC:11877UniProt:P57727
S1PR2Sphingosine 1-phosphate receptor 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Receptor for the lysosphingolipid sphingosine 1-phosphate (S1P) (PubMed:10617617, PubMed:25274307). S1P is a bioactive lysophospholipid that elicits diverse physiological effects on most types of cells and tissues (PubMed:10617617). When expressed in rat HTC4 hepatoma cells, is capable of mediating S1P-induced cell proliferation and suppression of apoptosis (PubMed:10617617). Receptor for the chemokine-like protein FAM19A5 (PubMed:29453251). Mediates the inhibitory effect of FAM19A5 on vascular

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
G alpha (i) signalling eventsLysosphingolipid and LPA receptors
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 68

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
36.8 TPM
Cervix Ectocervix
29.6 TPM
Pulmão
29.4 TPM
Cervix Endocervix
29.4 TPM
Linfócitos
24.9 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 68hearing loss, autosomal recessive
HGNC:3169UniProt:O95136
CLDN14Claudin-14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity

LOCALIZAÇÃO

Cell junction, tight junctionCell membrane

VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 29

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 29hearing loss, autosomal recessive
HGNC:2035UniProt:O95500
PCDH15Protocadherin-15Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium-dependent cell-adhesion protein. Essential for maintenance of normal retinal and cochlear function

LOCALIZAÇÃO

Cell membraneSecreted

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1F

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Baixa expressão)
Hipotálamo
2.4 TPM
Cérebro - Amígdala
2.0 TPM
Hipocampo
1.8 TPM
Brain Anterior cingulate cortex BA24
1.7 TPM
Substância negra
1.7 TPM
OUTRAS DOENÇAS (5)
Usher syndrome type 1Fautosomal recessive nonsyndromic hearing loss 23Usher syndrome type 1DUsher syndrome type 1
HGNC:14674UniProt:Q96QU1
CLRN2Clarin-2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a key role to hearing function. Required for normal organization and maintenance of the stereocilia bundle and for mechano-electrical transduction

LOCALIZAÇÃO

Cell projection, stereocilium membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 117

A form of non-syndromic deafness characterized by prelingual, moderate-to-profound sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (1)
hearing loss, autosomal recessive 117
HGNC:HGNC:33939UniProt:A0PK11
MYO3AMyosin-IIIaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Actin-dependent motor protein with a protein kinase activity, playing an essential role in hearing (PubMed:12032315, PubMed:29880844, PubMed:34788109). Probably also plays a role in vision. Required for normal cochlear hair bundle development and hearing. Plays an important role in the early steps of cochlear hair bundle morphogenesis. Influences the number and lengths of stereocilia to be produced and limits the growth of microvilli within the forming auditory hair bundles thereby contributing

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasmCell projection, filopodium tipCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 30

A form of non-syndromic deafness characterized by bilateral progressive hearing loss, which first affects the high frequencies. Hearing loss begins in the second decade, and by age 50 is severe in high and middle frequencies and moderate at low frequencies.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
6.3 TPM
Artéria tibial
2.0 TPM
Brain Nucleus accumbens basal ganglia
1.3 TPM
Brain Caudate basal ganglia
0.7 TPM
Pituitária
0.6 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 90autosomal recessive nonsyndromic hearing loss 30hearing loss, autosomal recessive
HGNC:7601UniProt:Q8NEV4
TBC1D24TBC1 domain family member 24Disease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as a GTPase-activating protein for Rab family protein(s) (PubMed:20727515, PubMed:20797691). Involved in neuronal projections development, probably through a negative modulation of ARF6 function (PubMed:20727515). Involved in the regulation of synaptic vesicle trafficking (PubMed:31257402)

LOCALIZAÇÃO

Cell membraneCytoplasmCytoplasmic vesicle membranePresynapse

VIAS BIOLÓGICAS (1)
TBC/RABGAPs
MECANISMO DE DOENÇA

Familial infantile myoclonic epilepsy

A subtype of idiopathic epilepsy starting in early infancy and manifesting as myoclonic seizures, febrile convulsions, and tonic-clonic seizures.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
27.8 TPM
Cérebro - Hemisfério cerebelar
26.6 TPM
Brain Frontal Cortex BA9
11.4 TPM
Córtex cerebral
11.2 TPM
Pituitária
9.4 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (11)
familial infantile myoclonic epilepsyrolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndromeautosomal dominant nonsyndromic hearing loss 65autosomal recessive nonsyndromic hearing loss 86
HGNC:29203UniProt:Q9ULP9
RIPOR2Rho family-interacting cell polarization regulator 2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Acts as an inhibitor of the small GTPase RHOA and plays several roles in the regulation of myoblast and hair cell differentiation, lymphocyte T proliferation and neutrophil polarization (PubMed:17150207, PubMed:23241886, PubMed:24687993, PubMed:24958875, PubMed:25588844, PubMed:27556504). Inhibits chemokine-induced T lymphocyte responses, such as cell adhesion, polarization and migration (PubMed:23241886). Involved also in the regulation of neutrophil polarization, chemotaxis and adhesion (By si

LOCALIZAÇÃO

CytoplasmCytoplasm, cytoskeletonCell projection, filopodiumCell projection, stereociliumCell projection, stereocilium membraneApical cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 104

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 21autosomal recessive nonsyndromic hearing loss 104hearing loss, autosomal recessive
HGNC:13872UniProt:Q9Y4F9
POU3F4POU domain, class 3, transcription factor 4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Probable transcription factor which exert its primary action widely during early neural development and in a very limited set of neurons in the mature brain

LOCALIZAÇÃO

Nucleus

MECANISMO DE DOENÇA

Deafness, X-linked, 2

A form of deafness characterized by both conductive hearing loss resulting from stapes (perilymphatic gusher) fixation, and progressive sensorineural deafness.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
28.9 TPM
Brain Caudate basal ganglia
17.4 TPM
Brain Putamen basal ganglia
10.9 TPM
Cerebelo
3.8 TPM
Brain Anterior cingulate cortex BA24
3.2 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (3)
X-linked mixed hearing loss with perilymphatic gusherchoroideremia-deafness-obesity syndromemitochondrial non-syndromic sensorineural hearing loss
HGNC:9217UniProt:P49335
KCNJ10ATP-sensitive inward rectifier potassium channel 10Disease-causing germline mutation(s) inModerado
FUNÇÃO

May be responsible for potassium buffering action of glial cells in the brain (By similarity). Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it (PubMed:8995301). Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages (PubMed:8995301). The inward rectification is mainly d

LOCALIZAÇÃO

MembraneBasolateral cell membrane

VIAS BIOLÓGICAS (3)
Activation of G protein gated Potassium channelsInhibition of voltage gated Ca2+ channels via Gbeta/gamma subunitsPotassium transport channels
MECANISMO DE DOENÇA

Seizures, sensorineural deafness, ataxia, impaired intellectual development, and electrolyte imbalance

A complex disorder characterized by generalized seizures with onset in infancy, delayed psychomotor development, ataxia, sensorineural hearing loss, hypokalemia, metabolic alkalosis, and hypomagnesemia.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Spinal cord cervical c-1
132.0 TPM
Brain Caudate basal ganglia
61.6 TPM
Substância negra
60.1 TPM
Brain Putamen basal ganglia
56.0 TPM
Córtex cerebral
49.6 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 4EAST syndromePendred syndromeepisodic kinesigenic dyskinesia
HGNC:6256UniProt:P78508
TMEM132ETransmembrane protein 132EDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for normal inner ear hair cell function and hearing

LOCALIZAÇÃO

Membrane

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
33.1 TPM
Cérebro - Hemisfério cerebelar
29.0 TPM
Córtex cerebral
6.9 TPM
Brain Frontal Cortex BA9
5.4 TPM
Hipotálamo
5.2 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 99hearing loss, autosomal recessive
HGNC:26991UniProt:Q6IEE7
PTPRQPhosphatidylinositol phosphatase PTPRQDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Dephosphorylates phosphatidylinositol phosphates, such as phosphatidylinositol 3,4,5-trisphosphate (PIP3) and phosphatidylinositol 3,5-diphosphates, with preference for PIP3 (PubMed:23897475). Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring (PubMed:23897475). Has low tyrosine-protein phosphatase activity in vitro; however, the relevance of such activity in vivo is unclear (By similarity). Plays an important role in adipogenesis of mesenchymal stem cells (MSCs). Regu

LOCALIZAÇÃO

Cell projection, stereociliumApical cell membraneBasal cell membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 84A

A form of non-syndromic deafness characterized by progressive, sensorineural hearing loss and vestibular dysfunction.

EXPRESSÃO TECIDUAL(Baixa expressão)
Tireoide
4.0 TPM
Fibroblastos
4.0 TPM
Rim - Córtex
3.1 TPM
Adipose Visceral Omentum
2.5 TPM
Pulmão
1.5 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 84Ahearing loss, autosomal dominant 73hearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:9679UniProt:Q9UMZ3
TMIETransmembrane inner ear expressed proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Auxiliary subunit of the mechanotransducer (MET) non-specific cation channel complex located at the tips of stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system. The MET complex is composed of two dimeric pore-forming ion-conducting transmembrane TMC (TMC1 or TMC2) subunits, and aided by several auxiliary proteins including LHFPL5, TMIE, CIB2/3 and TOMT, and the tip-link PCDH15. May contribute to the formation of the pore

LOCALIZAÇÃO

Membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 6

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Pituitária
19.1 TPM
Hipotálamo
16.1 TPM
Brain Frontal Cortex BA9
12.2 TPM
Córtex cerebral
11.4 TPM
Brain Anterior cingulate cortex BA24
8.9 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 6hearing loss, autosomal recessive
HGNC:30800UniProt:Q8NEW7
ESRRBSteroid hormone receptor ERR2Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor that binds a canonical ESRRB recognition (ERRE) sequence 5'TCAAGGTCA-3' localized on promoter and enhancer of targets genes regulating their expression or their transcription activity (PubMed:17920186, PubMed:19755138). Plays a role, in a LIF-independent manner, in maintainance of self-renewal and pluripotency of embryonic and trophoblast stem cells through different signaling pathways including FGF signaling pathway and Wnt signaling pathways. Involved in morula development

LOCALIZAÇÃO

NucleusCytoplasmChromosome

VIAS BIOLÓGICAS (1)
Nuclear Receptor transcription pathway
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 35

A form of non-syndromic deafness characterized by non-progressive, prelingual hearing loss.

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Medula
11.8 TPM
Estômago
3.6 TPM
Testículo
3.5 TPM
Rim - Córtex
2.8 TPM
Músculo esquelético
1.7 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 35hearing loss, autosomal recessive
HGNC:3473UniProt:O95718
TRIOBPTRIO and F-actin-binding proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Regulates actin cytoskeletal organization, cell spreading and cell contraction by directly binding and stabilizing filamentous F-actin and prevents its depolymerization (PubMed:18194665, PubMed:28438837). May also serve as a linker protein to recruit proteins required for F-actin formation and turnover (PubMed:18194665). Essential for correct mitotic progression (PubMed:22820163, PubMed:24692559) Plays a pivotal role in the formation of stereocilia rootlets Plays a pivotal role in the formation

LOCALIZAÇÃO

NucleusCytoplasm, cytoskeleton, microtubule organizing center, centrosomeMidbodyChromosome, telomere

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 28

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cervix Ectocervix
50.5 TPM
Cervix Endocervix
49.5 TPM
Útero
45.5 TPM
Vagina
40.2 TPM
Fallopian Tube
39.1 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 28hearing loss, autosomal recessive
HGNC:17009UniProt:Q9H2D6
OTOAOtoancorinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

May act as an adhesion molecule

LOCALIZAÇÃO

Apical cell membraneSecreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Post-translational modification: synthesis of GPI-anchored proteins
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 22

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Testículo
6.0 TPM
Baço
1.0 TPM
Pituitária
0.4 TPM
Brain Frontal Cortex BA9
0.3 TPM
Córtex cerebral
0.2 TPM
INTERAÇÕES PROTEICAS (3)
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 22hearing loss, autosomal recessive
HGNC:16378UniProt:Q7RTW8
USH1CHarmoninDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Anchoring/scaffolding protein that is a part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for normal development and maintenance of cochlear hair cell bundles (By similarity). As part of the intermicrovillar adhesion complex/IMAC plays a role in brush border differentiation, controlling microvilli organization and length. Probably plays a central regulatory role in the assembly of the complex, recruiting CDHR

LOCALIZAÇÃO

Cytoplasm, cytosolCytoplasm, cytoskeletonCell projection, microvillus

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1C

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Tecido-específico)
Intestino delgado
33.0 TPM
Brain Spinal cord cervical c-1
31.6 TPM
Cólon transverso
27.2 TPM
Rim - Córtex
23.4 TPM
Rim - Medula
9.9 TPM
OUTRAS DOENÇAS (4)
autosomal recessive nonsyndromic hearing loss 18AUsher syndrome type 1CUsher syndrome type 1hearing loss, autosomal recessive
HGNC:12597UniProt:Q9Y6N9
CEACAM16Cell adhesion molecule CEACAM16Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for proper hearing, plays a role in maintaining the integrity of the tectorial membrane

LOCALIZAÇÃO

Secreted

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4B

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (4)
hearing loss, autosomal recessive 113autosomal dominant nonsyndromic hearing loss 4Bhearing loss, autosomal recessiveautosomal dominant nonsyndromic hearing loss
HGNC:31948UniProt:Q2WEN9
EYA4Protein phosphatase EYA4Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Tyrosine phosphatase that specifically dephosphorylates 'Tyr-142' of histone H2AX (H2AXY142ph). 'Tyr-142' phosphorylation of histone H2AX plays a central role in DNA repair and acts as a mark that distinguishes between apoptotic and repair responses to genotoxic stress. Promotes efficient DNA repair by dephosphorylating H2AX, promoting the recruitment of DNA repair complexes containing MDC1. Its function as histone phosphatase probably explains its role in transcription regulation during organog

LOCALIZAÇÃO

CytoplasmNucleus

VIAS BIOLÓGICAS (1)
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 10

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Músculo esquelético
16.8 TPM
Próstata
5.8 TPM
Pituitária
5.6 TPM
Cervix Endocervix
5.1 TPM
Cervix Ectocervix
3.9 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 10dilated cardiomyopathy 1Jautosomal dominant nonsyndromic hearing loss
HGNC:3522UniProt:O95677
FOXI1Forkhead box protein I1Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Transcriptional activator required for the development of normal hearing, sense of balance and kidney function. Required for the expression of SLC26A4/PDS, JAG1 and COCH in a subset of epithelial cells and the development of the endolymphatic system in the inner ear. Also required for the expression of SLC4A1/AE1, SLC4A9/AE4, ATP6V1B1 and the differentiation of intercalated cells in the epithelium of distal renal tubules (By similarity)

LOCALIZAÇÃO

Nucleus

EXPRESSÃO TECIDUAL(Tecido-específico)
Rim - Córtex
32.3 TPM
Rim - Medula
24.0 TPM
Glândula salivar
8.9 TPM
Skin Sun Exposed Lower leg
4.0 TPM
Skin Not Sun Exposed Suprapubic
2.5 TPM
INTERAÇÕES PROTEICAS (4)
OUTRAS DOENÇAS (3)
autosomal recessive nonsyndromic hearing loss 4autosomal recessive distal renal tubular acidosisPendred syndrome
HGNC:3815UniProt:Q12951
CABP2Calcium-binding protein 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Required for sound encoding at inner hair cells (IHCs) synapses, likely via inhibition of the inactivation of voltage-gated calcium channel of type 1.3 (Cav1.3) in the IHCs (PubMed:28183797). Required for the normal transfer of light signals through the retina (By similarity)

LOCALIZAÇÃO

Cytoplasm, perinuclear regionCell membraneGolgi apparatus

VIAS BIOLÓGICAS (1)
Sensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 93

A form of non-syndromic deafness characterized by stable, bilateral, symmetric, prelingual moderate to severe deafness. Hearing impairment is slightly more pronounced in the mid-frequencies, resulting in a distinctive shallow U-shaped audiogram.

INTERAÇÕES PROTEICAS (1)
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 93hearing loss, autosomal recessive
HGNC:1385UniProt:Q9NPB3
OTOFOtoferlinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Key calcium ion sensor involved in the Ca(2+)-triggered synaptic vesicle-plasma membrane fusion and in the control of neurotransmitter release at these output synapses. Interacts in a calcium-dependent manner to the presynaptic SNARE proteins at ribbon synapses of cochlear inner hair cells (IHCs) to trigger exocytosis of neurotransmitter. Also essential to synaptic exocytosis in immature outer hair cells (OHCs). May also play a role within the recycling of endosomes (By similarity)

LOCALIZAÇÃO

Cytoplasmic vesicle, secretory vesicle, synaptic vesicle membraneBasolateral cell membraneEndoplasmic reticulum membraneGolgi apparatus membranePresynaptic cell membraneCell membraneGolgi apparatus, trans-Golgi network

VIAS BIOLÓGICAS (1)
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 9

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Brain Nucleus accumbens basal ganglia
18.4 TPM
Brain Caudate basal ganglia
11.2 TPM
Brain Putamen basal ganglia
8.0 TPM
Hipotálamo
2.0 TPM
Testículo
2.0 TPM
OUTRAS DOENÇAS (3)
autosomal recessive nonsyndromic hearing loss 9nonsyndromic genetic hearing losshearing loss, autosomal recessive
HGNC:8515UniProt:Q9HC10
TPRNTaperinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Essential for hearing (By similarity). Required for maintenance of stereocilia on both inner and outer hair cells (By similarity). Necessary for the integrity of the stereociliary rootlet (By similarity). May act as an actin cytoskeleton regulator involved in the regulation of actin dynamics at the pointed end in hair cells (By similarity). Forms rings at the base of stereocilia and binds actin filaments in the stereocilia which may stabilize the stereocilia (By similarity). Acts as a strong inh

LOCALIZAÇÃO

Cell projection, stereociliumCell projection, microvillusNucleus, nucleoplasmCytoplasm

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 79

A form of non-syndromic deafness characterized by progressive and severe sensorineural hearing loss. There are no symptoms of vestibular dysfunction.

EXPRESSÃO TECIDUAL(Ubíquo)
Cerebelo
122.5 TPM
Cérebro - Hemisfério cerebelar
121.4 TPM
Pâncreas
55.4 TPM
Brain Spinal cord cervical c-1
35.6 TPM
Estômago
35.6 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 79hearing loss, autosomal recessive
HGNC:26894UniProt:Q4KMQ1
SLC26A4PendrinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Sodium-independent transporter of chloride and iodide (PubMed:10192399, PubMed:11932316, PubMed:12107249, PubMed:16684826, PubMed:24051746). Mediates electroneutral chloride-bicarbonate, chloride-iodide and chloride-formate exchange with 1:1 stoichiometry (PubMed:10644529, PubMed:15155570, PubMed:24051746, PubMed:35601831). Mediates electroneutral iodide-bicarbonate exchange (By similarity)

LOCALIZAÇÃO

Cell membraneApical cell membrane

VIAS BIOLÓGICAS (1)
Inorganic anion exchange by SLC26 transporters
MECANISMO DE DOENÇA

Pendred syndrome

An autosomal recessive disorder characterized by congenital sensorineural hearing loss in association with thyroid goiter. The disorder may account for up to 10% of the cases of hereditary deafness. The deafness is most often associated with a Mondini cochlear defect. Deafness occurs early, starting at birth or during the first years of life. It is bilateral, sometimes asymmetrical, fluctuant and often progressive. Thyroid perturbations, such as thyroid goiter and/or hypothyroidism appear most commonly during adolescence, but they can be congenital or appear later.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
136.5 TPM
Brain Frontal Cortex BA9
3.3 TPM
Brain Anterior cingulate cortex BA24
3.0 TPM
Córtex cerebral
2.7 TPM
Rim - Córtex
2.2 TPM
OUTRAS DOENÇAS (5)
Pendred syndromeautosomal recessive nonsyndromic hearing loss 4thyroid hypoplasiaathyreosis
HGNC:8818UniProt:O43511
STRCStereocilinDisease-causing germline mutation(s) inRestrito
FUNÇÃO

Essential to the formation of horizontal top connectors between outer hair cell stereocilia

LOCALIZAÇÃO

Cell surfaceCell projection, kinociliumCell projection, stereocilium

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 16

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
15.2 TPM
Cérebro - Hemisfério cerebelar
12.3 TPM
Testículo
4.9 TPM
Córtex cerebral
1.2 TPM
Pituitária
1.0 TPM
OUTRAS DOENÇAS (3)
autosomal recessive nonsyndromic hearing loss 16deafness-infertility syndromehearing loss, autosomal recessive
HGNC:16035UniProt:Q7RTU9
PKHD1L1Fibrocystin-LDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of hair-cell stereocilia coat. Required for normal hearing

LOCALIZAÇÃO

MembraneCell projection, stereocilium membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 124

A form of non-syndromic deafness characterized by progressive sensorineural hearing loss with onset at birth. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Tecido-específico)
Tireoide
70.8 TPM
Adipose Visceral Omentum
15.6 TPM
Fallopian Tube
7.0 TPM
Pulmão
5.5 TPM
Coração - Átrio
3.5 TPM
OUTRAS DOENÇAS (1)
autosomal recessive nonsyndromic hearing loss 124
HGNC:HGNC:20313UniProt:Q86WI1
MINAR2Major intrinsically disordered NOTCH2-binding receptor 1-likeDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Binds cholesterol and may regulate the distribution and homeostasis of cholesterol in hair cells (PubMed:36317962). May play a role in angiogenesis (PubMed:35727972)

LOCALIZAÇÃO

Lysosome membraneEndoplasmic reticulum membrane

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 120

A form of non-syndromic deafness characterized by congenital or prelingual onset of severe to profound sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 120hearing loss, autosomal recessive
HGNC:33914UniProt:P59773
CDH23Cadherin-23Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells. CDH23 is required for establishing and/or maintaining the proper organization of the stereocilia bundle of hair cells in the cochlea and the vestibule during late embryonic/early postnatal development. It is part of the functional network formed by USH1C, USH1G, CDH23 and MYO7A that mediates mechanotransduction in cochlear hair cells. Required for norma

LOCALIZAÇÃO

Cell membrane

VIAS BIOLÓGICAS (2)
Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1D

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

OUTRAS DOENÇAS (12)
autosomal recessive nonsyndromic hearing loss 12Usher syndrome type 1Dnonsyndromic genetic hearing lossUsher syndrome
HGNC:13733UniProt:Q9H251
USP48Ubiquitin carboxyl-terminal hydrolase 48Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Deubiquitinase that recognizes and hydrolyzes the peptide bond at the C-terminal Gly of ubiquitin. Involved in the processing of polyubiquitin precursors as well as that of ubiquitinated proteins (PubMed:16214042, PubMed:34059922). Plays a role in the regulation of NF-kappa-B activation by TNF receptor superfamily via its interactions with RELA and TRAF2. May also play a regulatory role at postsynaptic sites. Plays an important role in cell cycle progression by deubiquitinating Aurora B/AURKB an

LOCALIZAÇÃO

CytoplasmNucleusCell projection, cilium

VIAS BIOLÓGICAS (1)
Ub-specific processing proteases
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 85

A form of non-syndromic, sensorineural hearing loss. Sensorineural hearing loss results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA85 is characterized by progressive hearing loss, with onset in childhood or young adulthood.

EXPRESSÃO TECIDUAL(Ubíquo)
Linfócitos
68.8 TPM
Cérebro - Hemisfério cerebelar
55.8 TPM
Cerebelo
55.3 TPM
Ovário
36.8 TPM
Glândula adrenal
35.5 TPM
OUTRAS DOENÇAS (3)
hearing loss, autosomal dominant 85autosomal dominant nonsyndromic hearing lossCushing disease due to pituitary adenoma
HGNC:18533UniProt:Q86UV5
TNCTenascinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Extracellular matrix protein implicated in guidance of migrating neurons as well as axons during development, synaptic plasticity as well as neuronal regeneration. Promotes neurite outgrowth from cortical neurons grown on a monolayer of astrocytes. Ligand for integrins alpha-8/beta-1, alpha-9/beta-1, alpha-V/beta-3 and alpha-V/beta-6. In tumors, stimulates angiogenesis by elongation, migration and sprouting of endothelial cells (PubMed:19884327)

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (2)
Post-translational protein phosphorylationRegulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 56

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA56 is characterized by progressive hearing impairment with postlingual onset.

EXPRESSÃO TECIDUAL(Ubíquo)
Artéria tibial
351.7 TPM
Cólon sigmoide
199.3 TPM
Fibroblastos
99.0 TPM
Rim - Medula
83.0 TPM
Artéria coronária
77.4 TPM
OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 56autosomal dominant nonsyndromic hearing loss
HGNC:5318UniProt:P24821
MIR96Disease-causing germline mutation(s) inDesconhecido
LOCALIZAÇÃO

OUTRAS DOENÇAS (2)
autosomal dominant nonsyndromic hearing loss 50autosomal dominant nonsyndromic hearing loss
HGNC:31648
MYH14Myosin-14Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping

LOCALIZAÇÃO

VIAS BIOLÓGICAS (6)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 4A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
109.7 TPM
Músculo esquelético
106.9 TPM
Skin Not Sun Exposed Suprapubic
97.8 TPM
Esôfago - Mucosa
66.6 TPM
Tireoide
53.2 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 4Aperipheral neuropathy-myopathy-hoarseness-hearing loss syndromeautosomal dominant nonsyndromic hearing loss
HGNC:23212UniProt:Q7Z406
COL11A1Collagen alpha-1(XI) chainDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

May play an important role in fibrillogenesis by controlling lateral growth of collagen II fibrils

LOCALIZAÇÃO

Secreted, extracellular space, extracellular matrix

VIAS BIOLÓGICAS (1)
Collagen biosynthesis and modifying enzymes
MECANISMO DE DOENÇA

Stickler syndrome 2

An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable.

OUTRAS DOENÇAS (8)
Marshall syndromeStickler syndrome type 2hearing loss, autosomal dominant 37fibrochondrogenesis 1
HGNC:2186UniProt:P12107
MYH9Myosin-9Disease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Cellular myosin that appears to play a role in cytokinesis, cell shape, and specialized functions such as secretion and capping. Required for cortical actin clearance prior to oocyte exocytosis (By similarity). Promotes cell motility in conjunction with S100A4 (PubMed:16707441). During cell spreading, plays an important role in cytoskeleton reorganization, focal contact formation (in the margins but not the central part of spreading cells), and lamellipodial retraction; this function is mechanic

LOCALIZAÇÃO

Cytoplasm, cytoskeletonCytoplasm, cell cortexCytoplasmic vesicle, secretory vesicle, Cortical granuleCell membrane

VIAS BIOLÓGICAS (10)
RHO GTPases activate PAKsRHO GTPases Activate ROCKsRHO GTPases activate PKNsRHO GTPases activate CITSema4D induced cell migration and growth-cone collapse
MECANISMO DE DOENÇA

Macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss

An autosomal dominant disorder characterized by thrombocytopenia, giant platelets and Dohle body-like inclusions in peripheral blood leukocytes with variable ultrastructural appearance. Some affected individuals lack leukocyte inclusion bodies on classic staining of peripheral blood smears. Alport syndrome-like features of nephritis, hearing loss, and eye abnormalities are present in some patients.

EXPRESSÃO TECIDUAL(Ubíquo)
Aorta
1592.3 TPM
Artéria tibial
1091.7 TPM
Útero
820.6 TPM
Artéria coronária
818.3 TPM
Pulmão
601.2 TPM
OUTRAS DOENÇAS (4)
autosomal dominant nonsyndromic hearing loss 17macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing lossnodular fasciitisautosomal dominant nonsyndromic hearing loss
HGNC:7579UniProt:P35579
MYO7AUnconventional myosin-VIIaDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails bind to membranous compartments, which are then moved relative to actin filaments. In the retina, plays an important role in the renewal of the outer photoreceptor disks. Plays an important role in the distribution and migration of retinal pigment epithelial (RPE) melanosomes and phagosomes, and in the regulation of opsin transport in retinal photore

LOCALIZAÇÃO

CytoplasmCytoplasm, cell cortexCytoplasm, cytoskeletonSynapse

VIAS BIOLÓGICAS (3)
The canonical retinoid cycle in rods (twilight vision)Sensory processing of sound by outer hair cells of the cochleaSensory processing of sound by inner hair cells of the cochlea
MECANISMO DE DOENÇA

Usher syndrome 1B

USH is a genetically heterogeneous condition characterized by the association of retinitis pigmentosa with sensorineural deafness. Age at onset and differences in auditory and vestibular function distinguish Usher syndrome type 1 (USH1), Usher syndrome type 2 (USH2) and Usher syndrome type 3 (USH3). USH1 is characterized by profound congenital sensorineural deafness, absent vestibular function and prepubertal onset of progressive retinitis pigmentosa leading to blindness.

EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
43.8 TPM
Glândula adrenal
40.7 TPM
Pituitária
27.6 TPM
Baço
20.4 TPM
Fígado
12.7 TPM
OUTRAS DOENÇAS (9)
autosomal dominant nonsyndromic hearing loss 11autosomal recessive nonsyndromic hearing loss 2Usher syndrome type 1Bnonsyndromic genetic hearing loss
HGNC:7606UniProt:Q13402
LRTOMTLeucine-rich repeat-containing protein 51Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

Cytoplasm

VIAS BIOLÓGICAS (1)
Enzymatic degradation of dopamine by COMT
EXPRESSÃO TECIDUAL(Ubíquo)
Testículo
56.6 TPM
Pituitária
9.6 TPM
Tireoide
8.8 TPM
Próstata
7.4 TPM
Cervix Endocervix
7.0 TPM
OUTRAS DOENÇAS (2)
autosomal recessive nonsyndromic hearing loss 63hearing loss, autosomal recessive
HGNC:25033UniProt:Q96E66
PDZD7PDZ domain-containing protein 7Disease-causing germline mutation(s) inTolerante
FUNÇÃO

In cochlear developing hair cells, essential in organizing the USH2 complex at stereocilia ankle links. Blocks inhibition of adenylate cyclase activity mediated by ADGRV1

LOCALIZAÇÃO

Cell projection, ciliumNucleusCell projection, stereocilium

MECANISMO DE DOENÇA

Deafness, autosomal recessive, 57

A form of non-syndromic, sensorineural deafness characterized by symmetric, bilateral hearing loss with onset in early childhood. Vestibular function is preserved. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNB57 severity ranges from moderate to severe.

EXPRESSÃO TECIDUAL(Tecido-específico)
Cerebelo
35.8 TPM
Cérebro - Hemisfério cerebelar
31.2 TPM
Pituitária
10.4 TPM
Brain Frontal Cortex BA9
10.3 TPM
Córtex cerebral
10.1 TPM
OUTRAS DOENÇAS (4)
hearing loss, autosomal recessive 57Usher syndrome type 2CUsher syndrome type 2Usher syndrome type 2A
HGNC:26257UniProt:Q9H5P4
GJB6Gap junction beta-6 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Ectodermal dysplasia 2, Clouston type

A form of ectodermal dysplasia, a heterogeneous group of disorders due to abnormal development of two or more ectodermal structures such as hair, teeth, nails and sweat glands, with or without any additional clinical sign. Each combination of clinical features represents a different type of ectodermal dysplasia. ECTD2 is an autosomal dominant condition characterized by atrichosis, nail hypoplasia and deformities, hyperpigmentation of the skin, normal teeth, normal sweat and sebaceous gland function. Palmoplantar hyperkeratosis is a frequent feature. Hearing impairment has been detected in few cases.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Esôfago - Mucosa
199.5 TPM
Vagina
198.2 TPM
Skin Sun Exposed Lower leg
51.2 TPM
Córtex cerebral
51.0 TPM
Skin Not Sun Exposed Suprapubic
48.1 TPM
OUTRAS DOENÇAS (7)
autosomal recessive nonsyndromic hearing loss 1Bautosomal recessive nonsyndromic hearing loss 1AClouston syndromeautosomal dominant nonsyndromic hearing loss 3B
HGNC:4288UniProt:O95452
CLDN9Claudin-9Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Plays a major role in tight junction-specific obliteration of the intercellular space, through calcium-independent cell-adhesion activity (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) entry into hepatic cells

LOCALIZAÇÃO

Cell junction, tight junctionCell membrane

VIAS BIOLÓGICAS (1)
Tight junction interactions
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 116

A form of non-syndromic deafness characterized by slowly progressive, moderate to profound sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

OUTRAS DOENÇAS (1)
hearing loss, autosomal recessive 116
HGNC:HGNC:2051UniProt:O95484
PPIP5K2Inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 2Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Bifunctional inositol kinase that acts in concert with the IP6K kinases IP6K1, IP6K2 and IP6K3 to synthesize the diphosphate group-containing inositol pyrophosphates diphosphoinositol pentakisphosphate, PP-InsP5, and bis-diphosphoinositol tetrakisphosphate, (PP)2-InsP4 (PubMed:17690096, PubMed:17702752, PubMed:21222653, PubMed:29590114). PP-InsP5 and (PP)2-InsP4, also respectively called InsP7 and InsP8, regulate a variety of cellular processes, including apoptosis, vesicle trafficking, cytoskel

LOCALIZAÇÃO

Cytoplasm, cytosol

VIAS BIOLÓGICAS (1)
Synthesis of pyrophosphates in the cytosol
MECANISMO DE DOENÇA

Deafness, autosomal recessive, 100

A form of non-syndromic, sensorineural deafness characterized by prelingual hearing impairment. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
11.5 TPM
Linfócitos
10.8 TPM
Artéria coronária
10.7 TPM
Cervix Ectocervix
10.7 TPM
Fibroblastos
10.5 TPM
OUTRAS DOENÇAS (2)
hearing loss, autosomal recessive 100hearing loss, autosomal recessive
HGNC:29035UniProt:O43314
GREB1LGREB1-like proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Plays a major role in early metanephros and genital development

LOCALIZAÇÃO

Membrane

MECANISMO DE DOENÇA

Renal hypodysplasia/aplasia 3

A severe, autosomal dominant disease encompassing a spectrum of kidney development defects. Clinical manifestations are highly variable and include bilateral or unilateral renal agenesis, renal aplasia, hypoplasia, (cystic) dysplasia, severe obstructive uropathy, and vesicoureteral reflux. Bilateral renal agenesis is almost invariably fatal in utero or in the perinatal period. Unilateral renal agenesis can lead to future health issues including end-stage renal disease.

EXPRESSÃO TECIDUAL(Tecido-específico)
Fallopian Tube
8.7 TPM
Tireoide
7.4 TPM
Testículo
6.8 TPM
Ovário
6.4 TPM
Aorta
4.6 TPM
OUTRAS DOENÇAS (4)
hearing loss, autosomal dominant 80renal hypodysplasia/aplasia 3bilateral renal agenesisrenal agenesis, unilateral
HGNC:31042UniProt:Q9C091
KCNQ4Potassium voltage-gated channel subfamily KQT member 4Disease-causing germline mutation(s) inRestrito
FUNÇÃO

Pore-forming subunit of the voltage-gated potassium (Kv) channel involved in the regulation of sensory cells excitability in the cochlea (PubMed:10025409, PubMed:34767770). KCNQ4/Kv7.4 channel is composed of 4 pore-forming subunits assembled as tetramers (PubMed:34767770). Promotes the outflow of potassium ions in the repolarization phase of action potential which plays a role in regulating membrane potential of excitable cells (PubMed:10025409, PubMed:11245603, PubMed:34767770). The channel con

LOCALIZAÇÃO

Basal cell membrane

VIAS BIOLÓGICAS (3)
Voltage gated Potassium channelsSensory processing of sound by inner hair cells of the cochleaSensory processing of sound by outer hair cells of the cochlea
MECANISMO DE DOENÇA

Deafness, autosomal dominant, 2A

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon sigmoide
34.4 TPM
Esôfago - Muscular
29.5 TPM
Esôfago - Junção
26.7 TPM
Artéria tibial
20.7 TPM
Útero
19.5 TPM
OUTRAS DOENÇAS (3)
autosomal dominant nonsyndromic hearing loss 2Anonsyndromic genetic hearing lossautosomal dominant nonsyndromic hearing loss
HGNC:6298UniProt:P56696
GRHL2Grainyhead-like protein 2 homologDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Transcription factor playing an important role in primary neurulation and in epithelial development (PubMed:25152456, PubMed:29309642). Binds directly to the consensus DNA sequence 5'-AACCGGTT-3' acting as an activator and repressor on distinct target genes (By similarity). During embryogenesis, plays unique and cooperative roles with GRHL3 in establishing distinct zones of primary neurulation. Essential for closure 3 (rostral end of the forebrain), functions cooperatively with GRHL3 in closure

LOCALIZAÇÃO

NucleusMembrane

MECANISMO DE DOENÇA

Deafness, autosomal dominant, 28

A form of non-syndromic sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA28 is characterized by mild to moderate hearing loss across most frequencies that progresses to severe loss in the higher frequencies by the fifth decade.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
41.4 TPM
Skin Sun Exposed Lower leg
39.8 TPM
Próstata
34.7 TPM
Esôfago - Mucosa
33.1 TPM
Glândula salivar
24.8 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (5)
autosomal dominant nonsyndromic hearing loss 28corneal dystrophy, posterior polymorphous, 4nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndromeposterior polymorphous corneal dystrophy
HGNC:2799UniProt:Q6ISB3

Variantes genéticas (ClinVar)

429 variantes patogênicas registradas no ClinVar.

🧬 AIFM1: GRCh37/hg19 Xq23-28(chrX:113417246-155233731)x1 ()
🧬 AIFM1: GRCh37/hg19 Xq26.1-26.3(chrX:128882432-134384406)x3 ()
🧬 AIFM1: NM_004208.4(AIFM1):c.955C>G (p.Leu319Val) ()
🧬 AIFM1: NM_004208.4(AIFM1):c.858+169A>G ()
🧬 AIFM1: NM_004208.4(AIFM1):c.1191T>G (p.Ala397=) ()
Ver todas no ClinVar

Vias biológicas (Reactome)

86 vias biológicas associadas aos genes desta condição.

WNT5A-dependent internalization of FZD2, FZD5 and ROR2 Formation of the beta-catenin:TCF transactivating complex HATs acetylate histones Ub-specific processing proteases Sensory processing of sound by inner hair cells of the cochlea Sensory processing of sound by outer hair cells of the cochlea Mitochondrial RNA degradation Primary multipotent pancreatic progenitor cell produces trunk bipotent pancreatic progenitor cell Trunk bipotent pancreatic progenitor cell produces pancreatic ductal cell Post-translational modification: synthesis of GPI-anchored proteins RNA Polymerase III Abortive And Retractive Initiation RNA Polymerase III Transcription Initiation From Type 1 Promoter RNA Polymerase III Transcription Initiation From Type 2 Promoter RNA Polymerase III Transcription Initiation From Type 3 Promoter RSV-host interactions Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal Separation of Sister Chromatids Resolution of Sister Chromatid Cohesion RHO GTPases Activate Formins Deposition of new CENPA-containing nucleosomes at the centromere Mitotic Prometaphase EML4 and NUDC in mitotic spindle formation Cam-PDE 1 activation 5-Phosphoribose 1-diphosphate biosynthesis G alpha (i) signalling events Gap junction assembly Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin XBP1(S) activates chaperone genes Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) Post-translational protein phosphorylation Lysine catabolism RHOA GTPase cycle RHOB GTPase cycle RHOC GTPase cycle CDC42 GTPase cycle RAC1 GTPase cycle RAC2 GTPase cycle RHOD GTPase cycle RHOQ GTPase cycle RHOG GTPase cycle RHOJ GTPase cycle RAC3 GTPase cycle RHOF GTPase cycle HDACs deacetylate histones Regulation of PTEN gene transcription NGF-stimulated transcription Potential therapeutics for SARS Regulation of NPAS4 gene transcription Collagen degradation Collagen biosynthesis and modifying enzymes Assembly of collagen fibrils and other multimeric structures Non-integrin membrane-ECM interactions MET activates PTK2 signaling Collagen chain trimerization Developmental Lineage of Pancreatic Ductal Cells Lysosphingolipid and LPA receptors Tight junction interactions TBC/RABGAPs Activation of G protein gated Potassium channels Potassium transport channels Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits Nuclear Receptor transcription pathway Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks Insertion of tail-anchored proteins into the endoplasmic reticulum membrane Inorganic anion exchange by SLC26 transporters Defective SLC26A4 causes Pendred syndrome (PDS) Integrin cell surface interactions Syndecan interactions ECM proteoglycans EPHA-mediated growth cone collapse Sema4D induced cell migration and growth-cone collapse RHO GTPases activate PKNs RHO GTPases activate CIT RHO GTPases Activate ROCKs RHO GTPases activate PAKs Translocation of SLC2A4 (GLUT4) to the plasma membrane Regulation of actin dynamics for phagocytic cup formation CD163 mediating an anti-inflammatory response FCGR3A-mediated phagocytosis Signaling by ALK fusions and activated point mutants The canonical retinoid cycle in rods (twilight vision) LRTOMT LRTOMT transfers Met to DA, forming 3MT Synthesis of pyrophosphates in the cytosol Voltage gated Potassium channels Positive Regulation of CDH1 Gene Transcription

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
·Pré-clínico1
Medicamentos catalogadosEnsaios clínicos· 0 medicamentos · 1 ensaio
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Surdez genética não sindrômica

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

🟢 Recrutando agora

1 pesquisa recrutando participantes. Converse com seu médico sobre a possibilidade de participar.

Outros ensaios clínicos

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
0 papers (10 anos)
#1

Late diagnosis of Heimler syndrome and review of the genetic and phenotypic spectrum.

Ophthalmic genetics2026 Feb

Heimler syndrome is a rare autosomal recessive disorder at the mild end of the peroxisomal biogenesis disorders (PBDs), characterized by sensorineural hearing loss, amelogenesis imperfecta, and retinal dystrophy. Nail abnormalities affect a minority. We present a 67-year-old woman diagnosed with non-syndromic retinitis pigmentosa in her fifties, who was later found to carry compound heterozygous variants in the PEX6 gene. Her medical history included prelingual hearing loss, early tooth decay, and brittle nails that were deemed unrelated for decades. Hearing loss and vision loss remained relatively stable up to last consultation. Our literature review includes 46 published Heimler syndrome cases with confirmed molecular diagnoses. Retinal dystrophy, predominantly of the rod-cone type with pigment clumping, was present in 89% of reported cases, with macular edema noted in 40%. Serum peroxisomal metabolite abnormalities seem to correlate with worse neurodevelopmental outcomes. There are no clear genotype-phenotype correlations, although residual peroxisomal function due to the presence of at least one missense, leaky splice site, or stable truncated allele explains the relatively mild phenotype for PBD. We underscore the importance to include syndromic disorders in the differential diagnosis of retinal dystrophy in older adults.

#2

Whole exome sequencing reveals novel and rare variants in nonsyndromic hearing loss-related genes: A focus on GPSM2 compound heterozygosity.

Journal of biosciences2025

Non-syndromic hearing loss (NSHL) is a genetically heterogeneous disorder affecting millions worldwide. Recent advances in genetic technologies have expanded our understanding of its molecular basis, but challenges remain in identifying and interpreting causative variants. This study aimed to investigate the genetic etiology of NSHL using comprehensive genetic screening, with a focus on identifying rare and potentially pathogenic variants. We performed genetic analysis on 43 participants diagnosed with NSHL using whole exome sequencing (WES) technology. Variant filtering, in silico prediction tools, and segregation analysis were employed to evaluate the pathogenicity of identified variants. Our analysis revealed 20 rare and deleterious variants (4 novel and 16 previously reported) in 16 NSHL-related genes among 43 participants. These variants included 3 known pathogenic, 4 likely pathogenic, and 13 variants of uncertain significance (VUS). Notably, we identified compound heterozygous variants in the GPSM2 gene (NM_013296:c.185G>A;p.Ser62Asn and NM_013296:c.1264delG;p.Val422Tyrfs*28) in one participant, with segregation analysis confirming their trans configuration. This study expands our understanding of the genetic landscape of NSHL by identifying several rare variants in known NSHL-related genes. Notably, we report the first case of compound heterozygous variants in the GPSM2 gene in the Indian population, a finding not previously documented. This discovery underscores the importance of comprehensive genetic screening in diverse populations and contributes to the growing body of evidence for the role of GPSM2 in NSHL.

#3

Mendelian non-syndromic and syndromic hearing loss genes contribute to presbycusis.

European journal of human genetics : EJHG2025 Jun

Age-related (AR) hearing loss (HL) is the most prevalent sensorineural disorder in older adults. Here we demonstrate that rare-variants in well-established Mendelian HL genes play an important role in ARHL etiology. In all we identified 32 Mendelian HL genes which are associated with ARHL. We performed single and rare-variant aggregate association analyses using exome data obtained from white-Europeans with self-reported hearing phenotypes from the UK Biobank. Our analysis revealed previously unreported associations between ARHL and rare-variants in Mendelian non-syndromic and syndromic HL genes, including MYO15A, and WFS1. Additionally, rare-variant aggregate association analyses identified associations with Mendelian HL genes i.e., ACTG1, GRHL2, KCNQ4, MYO7A, PLS1, TMPRSS3, and TNRC6B. Four novel ARHL genes were also detected: FBXO2 and PALM3, implicated in HL in mice, TWF1, associated with HL in Dalmatian dogs, and TXNDC17. In-silico analyses provided further evidence of inner ear expression of these genes in both murine and human models, supporting their relevance to ARHL. Analysis of variants with minor allele frequency >0.005 revealed additional ARHL associations with known e.g., ILDR1 and novel i.e., ABHD12, COA8, KANSL1, SERAC1, and UBE3B Mendelian non-syndromic and syndromic HL genes as well as ARHL associations with genes that have not been previously reported to be involved in HL e.g., VCL. Rare-variants in Mendelian HL genes typically exhibited higher effect sizes for ARHL compared to those in other associated genes. In conclusion, this study highlights the critical role Mendelian non-syndromic and syndromic HL genes play in the etiology of ARHL.

#4

Leveraging underrepresented population data improves interpretation of genetic variants associated with hearing loss.

Scientific reports2025 Sep 29

Hearing loss is genetically heterogeneous, with over 121 implicated genes. Minor allele frequency (MAF) data from population databases greatly aid variant interpretation; however, these databases are predominantly based on individuals of European ancestry and lack sufficient East Asian representation, limiting accurate interpretation in under-represented populations. We analyzed rare variants associated with non-syndromic hearing loss classified as pathogenic, likely pathogenic, or of uncertain significance in the Deafness Variation Database (DVD). Population allele frequencies from 9,579 Koreans, 54,000 Japanese, and 651 patients with sensorineural hearing loss were evaluated. Of the 6,381 pathogenic or likely pathogenic variants cataloged in the DVD, 216 (3.38%) were detected in Korean population. Among these, 31 variants exhibited high allele frequencies that exceeded thresholds typically applied to identify benign variants in clinical interpretation guidelines. Of these, 6 remained disease-causing, including 4 East Asian founder alleles and one MYO7A variant common in Koreans. Our pipeline identified 24 variants for reclassification as benign or likely benign, and one P2RX2 variant of uncertain significance. Of 1,299,211 VUS, 3,736 were reclassified as benign. A substantial number of variants previously classified as pathogenic were reclassified as benign using MAF data from under-represented populations, highlighting the need for large-scale sequencing in diverse ancestries.

#5

The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.

Diabetologia2025 Oct

Biallelic pathogenic variants in SLC19A2 (the solute carrier family 19 member 2, which encodes thiamine transporter 1, responsible for thiamine intake) cause a recessive syndromic diabetes of infancy or early childhood in the context of thiamine-responsive megaloblastic anaemia, characterised by sensorineural deafness. Indeed, it has been reported, although only once, that even a heterozygous missense loss-of-function variant of SLC19A2 causes dominantly inherited non-syndromic diabetes. Finally, it is unknown whether rare SLC19A2 pathogenic variants modulate the risk of type 2 diabetes at the population level. We investigated the role of SLC19A2 heterozygous variants in both autosomal dominant mild hyperglycaemia and type 2 diabetes. We performed whole exome sequencing in two probands with mild hyperglycaemia and in 191,140 samples from the UK Biobank. Here we report two different heterozygous missense likely pathogenic variants of SLC19A2 (NM_006996.2) associated with non-syndromic mild hyperglycaemia in two pedigrees (c.515G>T and c.1063A>C missense variants, respectively), clearly confirming the only report available so far suggesting this link. In both pedigrees, individuals who carried an additional variant in one of the established monogenic diabetes genes (i.e. PDX1, NM_000209.3 and KCNJ11, NM_000525.3) showed an anticipation of disease onset of 25-31 years. Finally, 12 rare null variants in SLC19A2 were associated with type 2 diabetes (p=0.00033; OR 3.7; 95% CI 1.3, 227) and increased HbA1c levels (p=0.019, effect [π]=2.2 ± 0.92) in the UK Biobank. Taken together with previous evidence, these data indicate that SLC19A2 variability modulates glucose homeostasis, from recessive syndromic diabetes, to autosomal dominant mild hyperglycaemia, to type 2 diabetes.

Publicações recentes

Ver todas no PubMed

📚 EuropePMCmostrando 87

2026

Late diagnosis of Heimler syndrome and review of the genetic and phenotypic spectrum.

Ophthalmic genetics
2025

Leveraging underrepresented population data improves interpretation of genetic variants associated with hearing loss.

Scientific reports
2025

The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.

Diabetologia
2025

Whole exome sequencing reveals novel and rare variants in nonsyndromic hearing loss-related genes: A focus on GPSM2 compound heterozygosity.

Journal of biosciences
2025

[Phenotypic and pathogenic variant analysis of an X-linked dominant inherited non-syndromic hearing loss pedigree].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2025

Mendelian non-syndromic and syndromic hearing loss genes contribute to presbycusis.

European journal of human genetics : EJHG
2025

Oligogenic effect is associated with the clinical heterogeneity of autosomal dominant deafness-15.

Scientific reports
2024

Next-Generation Sequencing of Chinese Children with Congenital Hearing Loss Reveals Rare and Novel Variants in Known and Candidate Genes.

Biomedicines
2024

Overview of typical dental abnormalities in rare genetic syndromes occurring in the Czech Roma population.

Bratislavske lekarske listy
2025

The phenotypic spectrum of CEP250 gene variants.

Ophthalmic genetics
2024

A case with short stature and proteinuria: atypical presentation of a family with m.3243A>G mutation.

The Turkish journal of pediatrics
2024

Revising pathogenesis of AP1S1-related MEDNIK syndrome: a missense variant in the AP1S1 gene as a causal genetic lesion.

Journal of molecular medicine (Berlin, Germany)
2024

Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing.

Cells
2024

A Novel Variant in the DIAPH1 Gene Causing Macrothrombocytopenia and Non-syndromic Hearing Loss in a Pediatric Saudi Girl.

Cureus
2024

High prevalence of exon-13 variants in USH2A-related retinal dystrophies in Taiwanese population.

Orphanet journal of rare diseases
2024

Mutation spectrum of hearing loss patients in Northwest China: Identification of 20 novel variants.

Molecular genetics &amp; genomic medicine
2024

Self-Reported Functional Vision in USH2A-Associated Retinal Degeneration as Measured by the Michigan Retinal Degeneration Questionnaire.

Investigative ophthalmology &amp; visual science
2024

The Segregation of p.Arg68Ter-CLDN14 Mutation in a Syrian Deaf Family, Phenotypic Variations, and Comparative Analysis with the GJB2 Gene.

Genes
2024

Current phenotypic and genetic spectrum of syndromic deafness in Tunisia: paving the way for precision auditory health.

Frontiers in genetics
2024

Investigation of a novel TBC1D24 variation causing autosomal dominant non-syndromic hearing loss.

Scientific reports
2023

Expanding Genotype-Phenotype Correlation of CLCNKA and CLCNKB Variants Linked to Hearing Loss.

International journal of molecular sciences
2023

Novel autosomal dominant TMC1 variants linked to hearing loss: insight into protein-lipid interactions.

BMC medical genomics
2023

Clinical relevance of the TECTA c.6183G>T variant identified in a family with autosomal dominant hearing loss: a case report.

Croatian medical journal
2023

Combined Presence in Heterozygosis of Two Variant Usher Syndrome Genes in Two Siblings Affected by Isolated Profound Age-Related Hearing Loss.

Biomedicines
2023

Functional Consequences of Pathogenic Variants of the GJB2 Gene (Cx26) Localized in Different Cx26 Domains.

Biomolecules
2023

Autosomal dominant non-syndromic hearing loss caused by a novel mutation in MYO7A: A case report and review of the literature.

World journal of clinical cases
2023

Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review.

Molecular genetics and metabolism reports
2023

Phenotypic and molecular basis of SIX1 variants linked to non-syndromic deafness and atypical branchio-otic syndrome in South Korea.

Scientific reports
2023

USH2A mutational spectrum causing syndromic and non-syndromic retinal dystrophies in a large cohort of Mexican patients.

Molecular vision
2023

Loss-of-function mutations in MYO15A and OTOF cause non-syndromic hearing loss in two Yemeni families.

Human genomics
2023

Insights into the pathophysiology of DFNA44 hearing loss associated with CCDC50 frameshift variants.

Disease models &amp; mechanisms
2023

Monogenic Causes of Low-Frequency Non-Syndromic Hearing Loss.

Audiology &amp; neuro-otology
2023

Rare Coding Variants in Patients with Non-Syndromic Vestibular Dysfunction.

Genes
2023

Calcium signaling and genetic rare diseases: An auditory perspective.

Cell calcium
2023

Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction.

HGG advances
2023

A novel frameshift variant of LMX1A that leads to autosomal dominant non-syndromic sensorineural hearing loss: functional characterization of the C-terminal domain in LMX1A.

Human molecular genetics
2022

Case report: De novo pathogenic variant in WFS1 causes Wolfram-like syndrome debuting with congenital bilateral deafness.

Frontiers in genetics
2022

Inherited Retinal Dystrophy in Southeastern United States: Characterization of South Carolina Patients and Comparative Literature Review.

Genes
2022

Retinal Phenotype of Patients with CLRN1-Associated Usher 3A Syndrome in French Light4Deaf Cohort.

Investigative ophthalmology &amp; visual science
2022

Whole exome analysis of patients in Japan with hearing loss reveals high heterogeneity among responsible and novel candidate genes.

Orphanet journal of rare diseases
2022

Genetic profiles of non-syndromic severe-profound hearing loss in Chinese Hans by whole-exome sequencing.

Gene
2022

Genomic study of a large family with complex neurological phenotype including hearing loss, imbalance and action tremor.

Neurobiology of aging
2022

Variant analysis of 92 Chinese Han families with hearing loss.

BMC medical genomics
2022

De Novo ACTG1 Variant Expands the Phenotype and Genotype of Partial Deafness and Baraitser-Winter Syndrome.

International journal of molecular sciences
2022

Evaluation of copy number variants for genetic hearing loss: a review of current approaches and recent findings.

Human genetics
2021

Prevalence and phenotypic features of diabetes due to recessive, non-syndromic WFS1 mutations.

European journal of endocrinology
2021

[Genetic testing of a Chinese pedigree affected with non-syndromic autosomal dominant deafness 15].

Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics
2021

Prediction and interpretation of rare missense variant in OTOG associated with hearing loss.

Genomics
2021

A New Pathogenic Variant in POU3F4 Causing Deafness Due to an Incomplete Partition of the Cochlea Paved the Way for Innovative Surgery.

Genes
2021

Molecular alteration in the Gap Junction Beta 2 (GJB2) gene associated with non-syndromic sensorineural hearing impairment.

Intractable &amp; rare diseases research
2020

Improving the Management of Patients with Hearing Loss by the Implementation of an NGS Panel in Clinical Practice.

Genes
2020

Genetic Spectrum of Syndromic and Non-Syndromic Hearing Loss in Pakistani Families.

Genes
2020

[Enlarged vestibular aqueduct syndrome-dehiscence syndromes-honeycomb mastoid : Pathophysiology and evidence for clinical differentiation].

HNO
2020

Insights into the pathophysiology of DFNA10 hearing loss associated with novel EYA4 variants.

Scientific reports
2020

Exome sequencing identifies PEX6 mutations in three cases diagnosed with Retinitis Pigmentosa and hearing impairment.

Molecular vision
2020

A novel variant in diaphanous homolog 1 (DIAPH1) as the cause of auditory neuropathy in a Chinese family.

International journal of pediatric otorhinolaryngology
2020

Clinical and genetic analysis of two wolfram syndrome families with high occurrence of wolfram syndrome and diabetes type II: a case report.

BMC medical genetics
2020

Novel Loss-of-Function Variants in CDC14A are Associated with Recessive Sensorineural Hearing Loss in Iranian and Pakistani Patients.

International journal of molecular sciences
2019

First-Line Molecular Genetic Evaluation of Autosomal Recessive Non-Syndromic Hearing Loss.

Turkish archives of otorhinolaryngology
2019

Rare KCNQ4 variants found in public databases underlie impaired channel activity that may contribute to hearing impairment.

Experimental &amp; molecular medicine
2019

A novel mutation in PRPS1 causes X-linked Charcot-Marie-Tooth disease-5.

Neuropathology : official journal of the Japanese Society of Neuropathology
2019

Whole-exome sequencing identifies a novel missense variant within LOXHD1 causing rare hearing loss in a Chinese family.

BMC medical genetics
2019

Mutation screening in non-syndromic hearing loss patients with cochlear implantation by massive parallel sequencing in Taiwan.

PloS one
2019

LHFPL5 mutation: A rare cause of non-syndromic autosomal recessive hearing loss.

European journal of medical genetics
2018

Genomic Landscape and Mutational Signatures of Deafness-Associated Genes.

American journal of human genetics
2018

Whole exome sequencing in adult-onset hearing loss reveals a high load of predicted pathogenic variants in known deafness-associated genes and identifies new candidate genes.

BMC medical genomics
2018

De novo variants in GREB1L are associated with non-syndromic inner ear malformations and deafness.

Human genetics
2018

GJB3/GJB6 screening in GJB2 carriers with idiopathic hearing loss: Is it necessary?

Journal of clinical laboratory analysis
2018

Identification of a MYO7A mutation in a large Chinese DFNA11 family and genotype-phenotype review for DFNA11.

Acta oto-laryngologica
2017

Common founder effects of hereditary hemochromatosis, Wilson´s disease, the long QT syndrome and autosomal recessive deafness caused by two novel mutations in the WHRN and TMC1 genes.

Hereditas
2018

A Novel Variant in SYNE4 Confirms its Causative Role in Sensorineural Hearing Loss.

Balkan medical journal
2017

Whole-exome sequencing to identify the cause of congenital sensorineural hearing loss in carriers of a heterozygous GJB2 mutation.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
2017

The genetic basis of deafness in populations of African descent.

Journal of genetics and genomics = Yi chuan xue bao
2017

An example of the utility of genomic analysis for fast and accurate clinical diagnosis of complex rare phenotypes.

Orphanet journal of rare diseases
2016

Mutations in eight small DFNB genes are not a frequent cause of non-syndromic hereditary hearing loss in Czech patients.

International journal of pediatric otorhinolaryngology
2015

[Analysis common gene mutation spots of 127 non-syndromic deafness natients in Guangxi Drovince].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
2016

Ferlins Show Tissue-Specific Expression and Segregate as Plasma Membrane/Late Endosomal or Trans-Golgi/Recycling Ferlins.

Traffic (Copenhagen, Denmark)
2016

Genomic copy number alterations in non-syndromic hearing loss.

Clinical genetics
2015

Characterising the spectrum of autosomal recessive hereditary hearing loss in Iran.

Journal of medical genetics
2016

Comprehensive genetic testing with ethnic-specific filtering by allele frequency in a Japanese hearing-loss population.

Clinical genetics
2016

A comprehensive catalogue of the coding and non-coding transcripts of the human inner ear.

Hearing research
2015

EPS8L2 is a new causal gene for childhood onset autosomal recessive progressive hearing loss.

Orphanet journal of rare diseases
2016

Mucolipidosis types II and III and non-syndromic stuttering are associated with different variants in the same genes.

European journal of human genetics : EJHG
2015

High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss.

Orphanet journal of rare diseases
2015

Homozygous TBC1D24 mutation in two siblings with familial infantile myoclonic epilepsy (FIME) and moderate intellectual disability.

Epilepsy research
2015

OSBPL2 encodes a protein of inner and outer hair cell stereocilia and is mutated in autosomal dominant hearing loss (DFNA67).

Orphanet journal of rare diseases
2015

Non-manifesting AHI1 truncations indicate localized loss-of-function tolerance in a severe Mendelian disease gene.

Human molecular genetics

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Surdez genética não sindrômica.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Surdez genética não sindrômica

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Late diagnosis of Heimler syndrome and review of the genetic and phenotypic spectrum.
    Ophthalmic genetics· 2026· PMID 41126390mais citado
  2. Whole exome sequencing reveals novel and rare variants in nonsyndromic hearing loss-related genes: A focus on GPSM2 compound heterozygosity.
    Journal of biosciences· 2025· PMID 40501086mais citado
  3. Mendelian non-syndromic and syndromic hearing loss genes contribute to presbycusis.
    European journal of human genetics : EJHG· 2025· PMID 40055553mais citado
  4. Leveraging underrepresented population data improves interpretation of genetic variants associated with hearing loss.
    Scientific reports· 2025· PMID 41023131mais citado
  5. The role of SLC19A2 variants in the wide spectrum of non-autoimmune abnormalities of glucose homeostasis.
    Diabetologia· 2025· PMID 40603556mais citado
  6. Oligogenic effect is associated with the clinical heterogeneity of autosomal dominant deafness-15.
    Sci Rep· 2025· PMID 39809934recente
  7. The phenotypic spectrum of CEP250 gene variants.
    Ophthalmic Genet· 2025· PMID 39610034recente
  8. Investigating Splice Defects in USH2A Using Targeted Long-Read Sequencing.
    Cells· 2024· PMID 39120292recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:87884(Orphanet)
  2. MONDO:0019497(MONDO)
  3. GARD:19091(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q9079046(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Surdez genética não sindrômica
Compêndio · Raras BR

Surdez genética não sindrômica

ORPHA:87884 · MONDO:0019497
Prevalência
Unknown
Herança
Autosomal dominant, Autosomal recessive, X-linked recessive
CID-10
H90.5 · Perda de audição neuro-sensorial não especificada
CID-11
Início
Infancy, Neonatal
Prevalência
0.0 (Worldwide)
UMLS
C5680182
Wikidata
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades